YOLFTbeta
17

Standard Chemical & Pharmaceutical Co Ltd

1720 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

55.70TWD+0.80 (+1.46%)

Price History

Full chart

Market Stats

Previous Close54.90
Open55.20
Day Range55.20 – 55.90
52-Week Range53.50 – 66.60
Volume212.08K
Market Cap11.03B
P/E (TTM)10.77
Forward P/E18.62
EPS5.21
Dividend Yield3.55%
Beta0.00
50-Day Avg56.44
200-Day Avg56.49

About

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Tzu-Ting Fan
  • Employees0
  • HeadquartersNo. 154, Kaiyuan Road, Tainan City, Taiwan, 73055, Taiwan
  • Websitehttps://www.standard.com.tw

Leadership

  • Mr. Tzu-Ting FanChairman of the Board & GM
  • Chin Wen ChangFinancial Officer, Accounting Officer & Corporate Governance Officer

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.30B1.32B1.52B1.68B1.92B2.01B2.18B2.28B2.89B3.33B3.37B3.05B3.30B3.32B3.67B3.85B3.57B3.94B4.31B4.60B5.85B6.24B6.79B7.02B
Growth (%)-+1.94%+14.47%+10.59%+14.80%+4.54%+8.47%+4.69%+26.69%+15.12%+1.25%-9.48%+7.91%+0.78%+10.61%+4.76%-7.16%+10.19%+9.35%+6.94%+27.09%+6.64%+8.81%+3.44%
Cost of Revenue546.33M540.66M622.38M685.87M913.22M984.17M1.12B1.24B1.66B2.00B2.06B1.76B1.85B1.83B2.10B2.10B2.03B2.23B2.39B2.54B3.36B3.51B3.80B4.11B
Gross Profit----1.01B1.03B1.06B1.05B1.23B1.33B1.31B1.30B1.45B1.50B1.58B1.75B1.54B1.71B1.92B2.07B2.49B2.73B2.99B2.91B
Gross Margin----52.55%51.08%48.71%45.92%42.49%39.98%38.97%42.49%43.93%45.01%42.91%45.44%43.23%43.41%44.59%44.91%42.51%43.68%44.02%41.42%
Operating Expense----654.10M718.41M730.48M746.51M906.66M1.12B1.10B1.03B1.07B1.11B1.16B1.21B1.15B1.12B1.15B1.05B1.05B1.47B1.59B1.55B
Operating Income172.12M202.29M233.99M328.30M357.09M309.14M332.53M302.66M323.34M207.46M214.57M265.19M377.32M383.49M418.14M541.48M398.78M590.24M774.06M1.02B1.44B1.26B1.40B1.36B
Operating Margin13.25%15.28%15.44%19.58%18.56%15.37%15.24%13.25%11.17%6.23%6.36%8.68%11.45%11.55%11.38%14.07%11.16%14.99%17.98%22.20%24.55%20.19%20.57%19.40%
EBITDA----487.49M437.54M444.46M417.90M482.96M475.93M477.36M516.62M527.09M666.30M688.04M756.38M727.80M808.65M1.01B1.25B1.66B1.58B2.06B1.80B
EBITDA Margin----25.33%21.75%20.37%18.29%16.69%14.28%14.15%16.92%15.99%20.06%18.73%19.65%20.37%20.54%23.49%27.11%28.30%25.31%30.32%25.58%
Net Income147.75M171.03M203.22M-323.44M267.71M274.60M293.46M210.05M246.75M271.43M298.39M374.24M347.89M340.22M363.29M374.36M376.48M524.17M706.73M1.15B834.89M880.50M927.66M
Net Income Margin11.38%12.92%13.41%-16.81%13.31%12.58%12.85%7.26%7.41%8.05%9.77%11.36%10.47%9.26%9.44%10.48%9.56%12.17%15.35%19.72%13.38%12.97%13.21%
R&D121.98M118.69M158.60M114.39M130.31M149.57M148.62M147.42M137.94M175.71M204.75M226.43M242.77M238.98M241.12M239.63M224.92M225.76M227.21M241.79M251.88M266.27M288.09M257.70M
R&D as % of Total Revenue9.39%8.96%10.46%6.82%6.77%7.44%6.81%6.45%4.77%5.27%6.07%7.41%7.37%7.20%6.56%6.23%6.29%5.73%5.28%5.25%4.30%4.27%4.24%3.67%
Interest Expense00009.71M4.82M4.65M4.60M8.93M10.77M11.13M9.59M6.35M4.06M3.59M6.53M9.01M10.47M7.57M7.25M18.77M25.79M15.07M8.45M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.50%0.24%0.21%0.20%0.31%0.32%0.33%0.31%0.19%0.12%0.10%0.17%0.25%0.27%0.18%0.16%0.32%0.41%0.22%0.12%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.85B3.28B3.40B3.43B3.49B3.31B3.55B3.84B4.52B4.87B5.12B5.35B5.37B5.80B6.23B6.37B6.44B6.93B7.05B10.10B10.97B11.19B11.18B11.80B
Total Liabilities1.28B1.62B1.60B1.02B911.85M726.66M943.47M1.04B1.61B1.74B1.82B1.77B1.77B1.91B2.03B2.17B2.19B2.28B2.14B3.30B3.53B3.05B2.20B2.51B
Total Equity1.58B1.66B1.80B2.26B2.43B2.45B2.48B2.68B2.70B2.90B3.00B3.29B3.30B3.54B3.72B3.67B3.68B3.76B3.97B4.34B4.75B5.30B5.91B6.12B
Cash153.65M167.50M174.04M220.49M298.89M230.78M597.59M952.79M787.21M705.91M963.09M767.94M543.23M766.38M876.82M1.19B1.25B1.47B1.04B2.56B2.26B2.04B1.52B1.83B
Total Debt----369.90M191.29M224.62M540.82M876.89M587.96M675.36M670.29M647.09M741.62M841.23M1.15B1.22B1.28B1.01B1.97B2.25B1.33B921.19M1.13B
Net Debt----71.01M-39.48M-372.97M-411.97M89.68M-117.96M-287.74M-97.65M103.85M-24.76M-35.59M-43.23M-35.90M-192.66M-22.99M-594.48M-11.62M-708.86M-598.93M-704.67M

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow147.75M272.89M335.45M370.77M358.75M323.60M719.17M634.23M272.47M405.49M402.25M427.26M582.30M650.87M305.38M708.74M484.94M637.94M922.58M827.03M1.23B1.34B1.69B1.87B
Investing Cash Flow----36.96M20.78M-174.92M-283.79M-399.75M-281.19M-94.01M-590.76M-285.87M-219.21M-364.83M-421.91M-139.53M-280.20M-710.17M819.12M-1.08B-485.50M-771.69M-1.31B
Financing Cash Flow-242.51M---317.31M-412.49M-177.82M5.68M113.51M-159.96M-45.26M-151.67M-530.52M-205.31M160.91M32.02M-284.81M-138.06M-643.98M-117.54M-465.44M-1.08B-1.44B-309.71M
Capital Expenditure192.54M149.81M40.95M50.78M95.01M72.72M192.50M266.14M309.66M298.50M246.76M422.73M177.53M178.98M177.92M385.64M169.36M179.11M352.49M217.92M1.20B625.70M599.61M489.28M
Free Cash Flow----263.74M250.88M526.67M368.09M-37.19M106.99M155.49M4.53M404.78M471.88M127.45M323.10M315.58M458.83M570.09M609.12M30.29M710.83M1.10B1.38B
Dividends Paid80.05M83.87M123.00M135.07M176.00M226.87M189.46M181.63M249.44M78.70M168.42M203.75M446.74M89.35M178.70M178.70M285.91M268.04M268.04M321.65M446.74M446.74M482.48M500.35M
FCF to OCF----73.52%77.53%73.23%58.04%-13.65%26.39%38.65%1.06%69.51%72.50%41.74%45.59%65.08%71.92%61.79%73.65%2.47%53.18%64.62%73.77%
Dividend Paid to FCF----66.73%90.43%35.97%49.34%-670.80%73.56%108.32%4495.79%110.37%18.93%140.21%55.31%90.60%58.42%47.02%52.81%1474.78%62.85%44.05%36.36%

Earnings

Report DateOct 28, 2007Aug 29, 2008Dec 3, 2008Feb 25, 2009Jun 3, 2009Aug 27, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011May 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 13, 2013Mar 28, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Nov 11, 2015Mar 29, 2016Jun 1, 2016Aug 31, 2016Nov 9, 2016Mar 28, 2017May 9, 2017Aug 9, 2017Nov 9, 2017Mar 26, 2018May 9, 2018Aug 10, 2018Nov 8, 2018Mar 25, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Mar 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 17, 2021May 5, 2021Sep 1, 2021Nov 2, 2021Mar 17, 2022May 11, 2022Aug 3, 2022Nov 17, 2022Mar 14, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Feb 29, 2024May 7, 2024Aug 7, 2024Nov 11, 2024Feb 25, 2025May 12, 2025Aug 6, 2025Nov 10, 2025
EPS Estimate0.530.37---0.41------0.40---------0.360.48------0.480.46---------------0.47---0.52----0.760.79--1.091.251.291.271.191.041.19-1.021.241.24
EPS Actual0.330.340.470.480.410.520.350.610.340.420.360.100.240.380.310.420.500.260.420.390.700.540.290.160.540.600.550.410.580.420.480.390.450.400.610.440.330.560.870.280.350.550.660.530.400.550.610.490.670.730.640.811.160.930.890.970.881.161.330.981.071.211.140.831.411.101.111.090.991.001.56
Surprise-37.74%-8.11%---26.83%-------40.00%----------19.44%-66.67%------0.00%-15.22%---------------4.26%---55.77%----15.79%46.84%---1.83%-3.20%-11.63%-34.65%18.49%5.77%-6.72%--2.94%-19.35%25.81%
TimingAfter-hoursPre-market---Pre-market------After-hours---------After-hoursAfter-hours------Pre-marketPre-market--After-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours---Pre-market---Pre-market---Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap11.03B
Enterprise Value9.74B
Trailing P/E10.77
Forward P/E18.62
PEG Ratio16.33
Price / Sales1.56
Price / Book1.78
EPS5.21
Book Value34.65
Revenue (TTM)7.08B
Gross Profit (TTM)3.02B
EBITDA1.86B
Profit Margin14.51%
Operating Margin21.78%
Return on Equity15.39%
Return on Assets7.59%
Shares Outstanding196.57M
Shares Float72.72M
Beta0.00
Dividend Yield3.55%
Dividend Rate2.00
Payout Ratio48.82%

Dividends

20231×
2.50Aug 4, 2023
20221×
2.50Jul 28, 2022
20211×
1.80Jul 29, 2021
20201×
1.50Jul 30, 2020
20191×
1.50Aug 1, 2019
20181×
1.60Aug 2, 2018
20171×
1.00Aug 2, 2017
20161×
1.00Aug 2, 2016
20151×
0.50Jul 31, 2015
20141×
2.50Jul 30, 2014
20131×
1.16Jul 30, 2013
20121×
1.00Aug 17, 2012
20111×
0.50Aug 19, 2011
20101×
1.50Aug 9, 2010
20091×
1.12Jul 20, 2009
20081×
1.13Jul 10, 2008
20071×
1.36Jul 11, 2007
20061×
1.06Jun 16, 2006
20051×
0.88Jul 14, 2005
20041×
0.88Aug 12, 2004
20031×
0.62Aug 14, 2003
20021×
0.60Aug 7, 2002
20011×
0.41Aug 7, 2001
20001×
0.39Jul 20, 2000

Stock Splits

  • Aug 19, 2011107:100
  • Jul 20, 2009103:100
  • Aug 18, 2006103:100
  • Aug 14, 2003103:100
  • Aug 7, 200221:20
  • Aug 7, 200121:20
  • Jul 20, 200011:10
  • Jul 21, 199923:20
  • Jul 30, 199823:20
  • Jul 25, 199723:20